9月28日Joachim Kohn教授(新泽西生物材料研究中心主任)学术报告
发布时间:2016-09-27   访问次数:178   作者:李玉林

报告题目:An update of recent progress in nerve, bone, and tooth regeneration at the New Jersey Center for Biomaterials 
开始时间: 2016-09-28,10:30 am
报告地点: 逸夫楼演讲厅
报告人: Joachim Kohn教授,新泽西生物材料研究中心主任,国际生物材料科学与工程学会联合会Fellow院主席

联系人:李玉林(实验15楼724)


主讲人简介:
Prof. Joachim Kohnis the director of the New Jersey Center for Biomaterials, and the Chair of the International College of Fellows of Biomaterials Science and Engineering.He has 69  issued US Patents on novel biomaterials and seven companies have licensed his technologies.Prof. Kohn has received many awards and honors, including the prestigious Thomas Alva Edison Patent Award, and the Clemson Award. His research interests ranges from synthetic polymer chemistry and materials science to drug delivery, cell biology, tissue engineering, and regenerative medicine.He pioneered the use of combinatorial and computational methods for the optimization of biomaterials for specific medical applications. He discovered "pseudo-poly(amino acid)s"- a new class of polymers, which have been used to develop medical devices for implantation in about 100,000 patients.

报告摘要:
The New Jersey Center for Biomaterials (NJCBM) is a leading research center that develops clinically useful therapies for a wide range of diseases. Some recent examples of clinically used products include hernia repair devices, an anti-microbial sleeve that prevents infections of implanted cardiac assist devices, and a coronary stent. New research is now focused on nerve, bone and tooth regeneration. For the treatment of peripheral nerve injuries, the NJCBM has developed a neurotrophic polymer (a material that supports nerve growth) that can be used to fabricate a nerve guidance tube with outstanding clinical properties. In the field of bone regeneration, new bone scaffolds have been developed that support bone growth exceptionally well. These devices are currently being tested in large animal models (goat and sheep) as the last stage before human clinical trials can be initiated. A major hurdle was the development of suitable manufacturing processes for human-sized implants. Finally, the very new and promising area of tooth regeneration will be discussed. Here, the goal is to create living tooth implants that can grow and develop like natural teeth. This work is still at the beginning but some promising progress has been made.